Neutropenia and anaemia due to carbimazole-dependent antibodies

Citation
J. Bux et al., Neutropenia and anaemia due to carbimazole-dependent antibodies, BR J HAEM, 109(1), 2000, pp. 243-247
Citations number
17
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BRITISH JOURNAL OF HAEMATOLOGY
ISSN journal
00071048 → ACNP
Volume
109
Issue
1
Year of publication
2000
Pages
243 - 247
Database
ISI
SICI code
0007-1048(200004)109:1<243:NAADTC>2.0.ZU;2-B
Abstract
Carbimazole-dependent antibodies to erythrocytes were detected in the sera of three anaemic patients who had been treated with carbimazole for hyperth yroidism. By the use of Rh-null-typed erythrocytes, we could show that some of these were directed against the proteins of the Rh complex. Carbimazole -dependent antibodies eluted from erythrocytes showed no binding to other b lood cells. One patient also presented with neutropenia and mild thrombocyt openia. Additional carbimazole-dependent antibodies against the neutrophil- specific Fc gamma receptor IIIb (Fc gamma RIIIb, CD16b) and the broadly exp ressed platelet endothelial cell adhesion molecule 1 (PECAM-1; CD31) were d etected in this patient's serum. Surprisingly, the PECAM-1-reactive drug-de pendent antibodies were also detectable in the sera of the other two patien ts with normal leucocyte and platelet counts. We assume that carbimazole ca n induce cell lineage-specific drug-dependent antibodies that cause cytopen ia and also drug-dependent antibodies against the broadly expressed PECAM-1 molecule that may cause mild but not severe cytopenia.